López-D’alessandro E, Mardenlli F, Paz M, Escovich L. Oral bisphosphonate-associated osteonecrosis of maxillary bone. A review of 18 cases. J Clin Exp Dent. 2014;6(5):e530-4.

 

doi:10.4317/jced.51694

http://dx.doi.org/doi:10.4317/jced.51694

 -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

References

1. Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006;16;144:753-61. PMID:16702591
http://dx.doi.org/10.7326/0003-4819-144-10-200605160-00009

 

2. Lazarovici TS, Yahalom R, Taicher S, Schwartz-Arad D, Peleg O, Yarom N. Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. J Oral Maxillofac Surg 2010;68:790-6.
http://dx.doi.org/10.1016/j.joms.2009.09.017
PMid:20307764

 

3. Junquera L, Gallego L, Pelaz A, Olay S. Oral bisphosphonates-associated osteonecrosis in rheumatoid arthritis. Med Oral Patol Oral Cir Bucal 2009;14:292-4. PMID:19300372

 

4. Sosa Henríquez M, Gómez de Tejada Romero MJ, Bagán Sebastián JV, Díaz Curiel M, Díez Pérez A, Jódar Gimeno E, et al. Osteonecrosis de los maxilares. Documento de consenso. Rev Osteoporos Metab Miner 2009;1:41-52. 5- Junquera LM, Acero J, Bargue-o M, de Vicente JC, Martín-Granizo R, Santamaría J, et al. Diagnóstico, prevención y tratamiento de la osteonecrosis de los maxilares por bifosfonatos. Recomendaciones de la sociedad espa-ola de cirugía oral y maxilofacial (SECOM). Cient Dent. 2008;5:229-37.

 

6. Advisory Task Force on bisphosphonate-related osteonecrosis ofthe jaws. American association of oral and maxillofacial sur-geons position paper on bisphosphonate-related osteonecrosisof the jaws. J Oral Maxillofac Surg. 2007;65:369-76.
http://dx.doi.org/10.1016/j.joms.2006.11.003
PMid:17307580

 

7. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE,Mehrotra B. American Association of Oral and Maxillofacial Sur-geons position paper on bisphosphonate-related osteonecrosisof the jaws-2009 update. J Oral Maxillofac Surg. 2009;67 (Suppl1):2-12.
PMid:19371809

 

8. Malden NJ, Pai AY. Oral bisphosphonate associated osteonecrosis of the jaws: three case reports. Br Dent J 2007; 203: 93-7.
http://dx.doi.org/10.1038/bdj.2007.636
PMid:17660780

 

9. Khosla S, Burr D, Cauley J, Dempster DW, Ebeling PR, Felsemberg D et al. Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task. Force of the American Society for Bone and Mineral Research (Editorial). J Bone Miner Res 2007; 22: 1479-91.
http://dx.doi.org/10.1359/jbmr.0707onj
PMid:17663640

 

10. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 2004;62:527-34.
http://dx.doi.org/10.1016/j.joms.2004.02.004
PMid:15122554

 

11. Bagan JV, Jiménez Y, Murillo J, Hernández S, Poveda R, Sanchís JM, Díaz JM, Scully C. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 2006;42:327-9.
http://dx.doi.org/10.1016/j.oraloncology.2005.08.001
PMid:16275156

 

12. Bocanegra-Pérez MS, Vicente-Barrero M, Sosa-Henríquez M, Rodríguez-Bocanegra E, Limiñana-Cañal JM, López-Márquez A, Pérez-Plasencia D, Ramos-Macías A. Estudio clínico y del metabolismo óseo en 44 pacientes con osteonecrosis de los maxilares asociada a bisfosfonatos. Med Oral Patol Oral Cir Bucal. 2013;18 (Ed. esp.):21-7.

 

13. Bagan JV, Murillo J, Jimenez Y, et al: Avascular jaw osteonecrosis in association with cancer chemotherapy: Series of 10 cases. J Oral Pathol Med 2005;34:120-3.
http://dx.doi.org/10.1111/j.1600-0714.2004.00269.x
PMid:15641993

 

14. Marín Fernández AB, Arjona Giménez C, de Dios Navarrete J. Osteonecrosis de los maxilares asociada al uso de bifosfonatos orales: a propósito de cinco casos. Rev Osteoporos Metab Miner 2012 4;1:37-41.

 

15. Bocanegra-Pérez S, Vicente-Barrero M, Sosa-Henríquez M, Gebaguer Blanco A, Knezevic M, Castellano-Navarro JM. Osteonecrosis maxilar secundaria al uso de bisfosfonatos por vía oral. Exposición de tres casos clínicos relacionados con alendronato. Rev Med Chile 2009;137:275-9.
http://dx.doi.org/10.4067/S0034-98872009000200014
PMid:19543652

 

16. Diniz-Freitas M, López-Cedrún JL, Fernández-Sanromán J, García- García A, Fernández-Feijoo J, Diz-Dios P. Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases in Spain. Med Oral Patol Oral Cir Bucal. 2012 Sep 1;17 (5):e751-8.
http://dx.doi.org/10.4317/medoral.18041
PMid:22549688 PMCid:PMC3482517